Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
3(21%)
Results Posted
10%(1 trials)

Phase Distribution

Ph not_applicable
3
21%
Ph early_phase_1
1
7%
Ph phase_3
3
21%
Ph phase_2
1
7%
Ph phase_4
1
7%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
3(33.3%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(3)
Completed(10)
Other(1)

Detailed Status

Completed10
Recruiting2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 21 (11.1%)
Phase 33 (33.3%)
Phase 41 (11.1%)
N/A3 (33.3%)

Trials by Status

active_not_recruiting17%
recruiting214%
completed1071%
unknown17%

Recent Activity

3 active trials
Showing 5 of 14
active_not_recruiting

Anticoagulation in Patients With Venous Thromboembolism and Cancer

NCT04618913
recruiting

Caprini Score in Venous Surgery: a Prospective Cohort Study

NCT03041805
completedphase_3

Reduced Anticoagulation Targets in ECLS (RATE)

NCT04536272
recruiting

Predictive Value of Modified Caprini Score and D-Dimer in Managing Lower Limb Venous Thrombosis in Cardiothoracic Patients

NCT06729021
completed

A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

NCT05112666
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT04618913

Anticoagulation in Patients With Venous Thromboembolism and Cancer

Active Not Recruiting
NCT03041805

Caprini Score in Venous Surgery: a Prospective Cohort Study

Recruiting
NCT04536272Phase 3

Reduced Anticoagulation Targets in ECLS (RATE)

Completed
NCT06729021

Predictive Value of Modified Caprini Score and D-Dimer in Managing Lower Limb Venous Thrombosis in Cardiothoracic Patients

Recruiting
NCT05112666

A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

Completed
NCT03044574Not Applicable

Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism

Completed
NCT04507282

Eosinophil and Anticoagulation in COVID-19 Patients

Completed
NCT03963336Early Phase 1

Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension

Completed
NCT02935530Phase 3

Thromboprophylaxis After Surgery for Gynecologic Malignancy in China

Completed
NCT02715492Phase 3

Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma.

Unknown
NCT01542723Not Applicable

Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy

Completed
NCT01542762Not Applicable

Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation

Completed
NCT02861105Phase 4

The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological Markers

Completed
NCT00827554Phase 2

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14